Urosepsis after ureterorenoscopy, intraoperative recognition of type-IV stones could change clinical practice
- PMID: 39306607
- DOI: 10.1007/s00345-024-05251-3
Urosepsis after ureterorenoscopy, intraoperative recognition of type-IV stones could change clinical practice
Abstract
Objectives: Urosepsis currently accounts for half of all post flexible ureterorenoscopy (F-URS) complications, with an incidence of up to 4.3%. It represents a quarter of all septic episodes in adults and 2% of hospital spendings. The primary objective of this study was to define the predictive clinical parameters that increase the risk of urosepsis after F-URS.
Subjects/patients (or materials) and methods: This prospective multicentric study evaluated patients who underwent F-URS for calculus between June 2016 and June 2018 in eleven French centers. Clinical, bacteriological, morpho-constitutional stone data, intraoperative information and complications were compared. Risk factors for postoperative urosepsis were identified and analyzed.
Results: We included 486 F-URS in 432 patients. The ureter was prepared using a double J stent in 51% of cases, a digital endoscope was used in 56% of patients with a median operative time of 120 min IQR (90-125) and using a sheath in 90% of cases. Postoperative urosepsis was observed in 18 patients (4%) with a median time to onset of 2 days IQR (1-5). The presence of coronary insufficiency: 3 (17%) vs 14 (3%) p = 0.005, a larger stone diameter: 11 cm [9-17] vs 10 cm [8-13] p = 0.02, a positive preoperative urine culture even when treated: 3 (17%) vs 56 (12%) p = 0.04, as well as the final composition of the type IV calculus (carbapatite or struvite) 5 (28%) vs 20 (4%) p < 0.001, were significantly associated with the occurrence of urosepsis. In multivariate analysis, only the presence of a type IV stone (OR = 14.0; p = 0.025) remained significant.
Conclusion: Ureteroscopic treatment of a type IV stone (carbapatite or struvite) in a patient should raise concerns about the risk of post-operative urosepsis. When recognized intraoperatively, they should lead to a pyelic urinary sample and prolonged clinical surveillance.
Keywords: Carbapatite; Renal stone; Stone composition; Struvite; Ureterorenoscopy; Urosepsis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Wagenlehner FM et al (2013) Diagnosis and management for urosepsis: items in urosepsis. Int J Urol. https://doi.org/10.1111/iju.12200 - DOI - PubMed
-
- C. M. Torio and B. J. Moore, “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013,” in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville (MD): Agency for Healthcare Research and Quality (US), 2006. Accessed: May 22, 2023. [Online]. http://www.ncbi.nlm.nih.gov/books/NBK368492/
-
- De Coninck V et al (2020) Complications of ureteroscopy: a complete overview. World J Urol 38(9):2147–2166. https://doi.org/10.1007/s00345-019-03012-1 - DOI - PubMed
-
- Somani BK et al (2017) Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. World J Urol 35(4):675–681. https://doi.org/10.1007/s00345-016-1909-0 - DOI - PubMed
-
- Haas CR, Li S, Knoedler MA, Penniston KL, Nakada SY (2023) Ureteroscopy and shock wave lithotripsy trends from 2012 to 2019 within the US medicare dataset: sharp growth in ureteroscopy utilization. J Endourol 37(2):219–224. https://doi.org/10.1089/end.2022.0402 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
